Preliminary Post-Mortem COVID-19 Evidence of Endothelial Injury and Factor VIII Hyperexpression

Luigi Cipolloni1, Francesco Sessa1, Giuseppe Bertozzi1

  • 1Department of Clinical and Experimental Medicine, University of Foggia, 71122 Foggia, Italy.

Insights

Autopsies reveal COVID-19 (coronavirus disease 2019) causes diffuse lung and endothelial damage, potentially explaining its thrombogenicity. Further post-mortem studies are crucial to understand this vascular component.

Area of Science:

  • Pathology
  • Infectious Diseases
  • Public Health

Background:

  • COVID-19 (coronavirus disease 2019) poses a significant public health threat.
  • Autoptic (post-mortem) studies on COVID-19 are scarce, limiting understanding of pathogenesis.
  • Autopsies are vital for determining the precise cause of death.

Purpose of the Study:

  • To highlight the importance of autopsies in diagnosing COVID-19 deaths.
  • To establish a histological and immunohistochemical protocol for diagnosing COVID-19 fatalities.
  • To investigate the role of endothelial damage and thrombogenicity in COVID-19.

Main Methods:

  • Histological and immunohistochemical examination of lung tissue from two COVID-19 deceased.
  • Comparison with a control case (newborn deceased from pneumonia).
  • Analysis of cellular and cytokine expression, ACE2, and Factor VIII (FVIII) positivity.

Main Results:

  • COVID-19 infection can induce acute respiratory distress syndrome (ARDS) via diffuse alveolar and endothelial damage.
  • Distinct cellular and cytokine expression patterns were observed in anti-COVID-19 antibody-positive cases versus controls.
  • Co-localization of COVID-19, ACE2, and FVIII positivity suggests a link between viral infection and endothelial damage.

Conclusions:

  • COVID-19, initially viewed as pneumonia, also exhibits characteristics of a vascular disease.
  • Widespread endothelial damage may contribute to the thrombogenicity observed in SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection.
  • Further post-mortem investigations are essential to elucidate the vascular hypothesis and individual susceptibility in COVID-19.

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
241
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.4K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
163
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.2K